Skip to main content
Log in

Dietary fats and diabetes mellitus: Is there a good fat?

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

As knowledge of the fatty acid functions has increased, so has the complexity of making dietary fat recommendations to people with type 2 diabetes. Oleic acid seems to offer a slight advantage over linoleic acid in reducing plasma glucose, insulin levels, total cholesterol, low-density lipoproteins (LDLs), and triglycerides, but may also have atherogenic properties through another mechanism. A diet containing a higher proportion of polyunsaturated fatty acids (PUFAs) may require a concomitant increase in antioxidant intake because PUFAs oxidize easily and are then converted to oxidized LDL, which is more atherogenic. In addition to raising total and LDL cholesterol, long chain saturated free fatty acids may interact with plasma glucose to increase insulin secretion. Omega-3 fatty acids decrease triglycerides and reduce the risk of fatal cardiac arrhythmias. Glycemic control does not appear to be adversely affected by omega-3 fatty acids at amounts of up to 3 g/d.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Marin P, Arver S: Androgens and abdominal obesity. Baillieres Clin Endocrinol Metab 1998, 12:441–451.

    Article  PubMed  CAS  Google Scholar 

  2. Korczowski MM: Dietary control of diabetes: reality or myth. South Med J 1985, 78:979–986.

    Article  PubMed  CAS  Google Scholar 

  3. Blades M, Morgan JB, Dickerson JWT: Dietary advice in the management of diabetes mellitus-history and current practice. J R Soc Health 1997, 117:143–150.

    PubMed  CAS  Google Scholar 

  4. Rifai N, Bachorik PS, Albers JJ: Lipids, lipoproteins, and apolipoproteins. In Tietz Fundamentals of Clinical Chemistry. Edited by Burtis CA, Ashwood ER. Philadelphia: W.B. Saunders Company; 2001:463–493.

    Google Scholar 

  5. Jonnalagadda SS, Mustad VA, Yu S, et al.: Effects of individual fatty acids on chronic diseases. Nutr Today 1996, 31:90–106.

    Article  Google Scholar 

  6. Segal-Isaacson CJ, Wylie-Rosett J: The cardiovascular effects of fish oils and omega-3 fatty acids. Heart Dis 1999, 1:149–154. Reviews the cardiovascular effects and mechanisms of omega-3 fatty acids, with an emphasis on studies investigating the effects of omega- 3 fatty acids on cardiac arrhythmias. It also discusses omega-3 fatty acid contents of common food sources.

    PubMed  CAS  Google Scholar 

  7. Bergman RN, Van Citters GW, Mittelman SD, et al.: Central role of the adipocyte in the metabolic syndrome. J Investig Med 2001, 49:119–126. Explores the relationships between visceral obesity and insulin resistance. It suggests that insulin regulation is mediated through the suppression of free fatty acid release from adipocytes when insulin binds adipocytes, which in turn reduces hepatic glucose output.

    PubMed  CAS  Google Scholar 

  8. Sauerland EK, Boileau JC: Grants Dissector. Philadelphia: Lippincott, Williams & Wilkins; 1999.

    Google Scholar 

  9. Bergman RN, Ader M: Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000, 11:351–356.

    Article  PubMed  CAS  Google Scholar 

  10. Stein DT, Stevenson BE, Chester MW, et al.: The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997, 100:398–403. Demonstrated that free fatty acids and glucose synergistically regulate insulin secretion and particularly at postprandial glucose levels, fatty acids directly increase insulin secretion in relation to their chain length and degree of saturation.

    PubMed  CAS  Google Scholar 

  11. Stein DT, Leiser M, Balent B, et al.: Differential effects of long chain ffa on glucose stimulated insulin release at physiological ffa/albumin molar ratios. Diabetes 2001, 50(suppl 2):A11.

    Google Scholar 

  12. Storlien LH, Jenkins AB, Chisholm DJ, et al.: Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991, 40:280–289.

    Article  PubMed  CAS  Google Scholar 

  13. Jucker BM, Cline GW, Barucci N, Shulman GI: Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes 1999, 48:134–140.

    Article  PubMed  CAS  Google Scholar 

  14. Garg A, Bonanome A, Grundy SM, et al.: Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988, 319:829–834.

    Article  PubMed  CAS  Google Scholar 

  15. Madigan C, Ryan M, Owens D, et al.: Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care 2000, 23:1472–1477. This recent randomized cross-over trial showed that fasting glucose and insulin levels were higher on a high linoleate diet compared to a high oleate diet in well-controlled men with type 2 diabetes. It also showed that the linoleate diet had higher amounts of atherogenic apo B48 and B100 in both VLDL and chylomicron particles.

    Article  PubMed  CAS  Google Scholar 

  16. Ryan M, McInerney D, Owens D, et al.: Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent vasoreactivity. QJM 2000, 93:85–91.

    Article  PubMed  CAS  Google Scholar 

  17. Griffin ME, Dimitriadis E, Lenehan K, et al.: Non-insulin-dependent diabetes mellitus: dietary monounsaturated fatty acids and low-density lipoprotein composition and function. QJM 1996, 89:211–216.

    PubMed  CAS  Google Scholar 

  18. Brynes AE, Edwards CM, Jadhav A, et al.: Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. Am J Clin Nutr 2000, 72:1111–1118.

    PubMed  CAS  Google Scholar 

  19. Salmeron J, Hu FB, Manson JE, et al.: Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001, 73:1019–1026.

    PubMed  CAS  Google Scholar 

  20. Clandinin MT, Wilke MS: Do trans fatty acids increase the incidence of type 2 diabetes? Am J Clin Nutr 2001, 73:1001–1002.

    PubMed  CAS  Google Scholar 

  21. Connor WE, Prince MJ, Ullmann D, et al.: The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control. Ann N Y Acad Sci 1993, 683:337–340.

    Article  PubMed  CAS  Google Scholar 

  22. Simopoulos AP: Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999, 70:560S-569S.

    PubMed  CAS  Google Scholar 

  23. Clarke SD: Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br J Nutr 2000, 83(suppl 1):S59-S66.

    PubMed  CAS  Google Scholar 

  24. Grey N, Kipnis DM: Effect of diet composition on the hyper-insulinemia of obesity. N Engl J Med 1971, 285:827–831.

    Article  PubMed  CAS  Google Scholar 

  25. Christiansen E, Schnider S, Palmvig B, et al.: Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 1997, 20:881–887.

    Article  PubMed  CAS  Google Scholar 

  26. Volek JS, Gomez AL, Kraemer WJ: Fasting lipoprotein and postprandial triacylglycerol responses to a low-carbohydrate diet supplemented with n-3 fatty acids. J Am Coll Nutr 2000, 19:383–391. Examined the effects of an 8-week ketogenic, high fat, very low carbohydrate diet on blood lipids in normal weight, healthy young men. Saturated fats were not increased from baseline diets, and fish oil supplements were administered daily. The study found that triglycerides were reduced by nearly 55% with no significant changes in total cholesterol, LDL, or HDL. Postprandial glucose was also reduced.

    PubMed  CAS  Google Scholar 

  27. Spanheimer RG: Reducing cardiovascular risk in diabetes. Which factors to modify first? Postgrad Med 2001, 109:26–30;

    PubMed  CAS  Google Scholar 

  28. Keyes A, Anderson JT, Grande F: Prediction of serum-cholesterol responses of man to change in fats in the diet. Lancet 1957, 2:959–966.

    Article  Google Scholar 

  29. Cheema SK, Agellon LB: Metabolism of cholesterol is altered in the liver of C3H mice fed fats enriched with different C-18 fatty acids. J Nutr 1999, 129:1718–1724.

    PubMed  CAS  Google Scholar 

  30. Kris-Etherton PM, Daniels SR, Eckel RH, et al.: AHA scientific statement: summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. Conference summary from the Nutrition Committee of the American Heart Association. J Nutr 2001, 131:1322–1326. Presents an excellent summary of current research on dietary fats and health, including the effects of fatty acids on insulin secretion, blood pressure, vascular activation, hemostatic factors, and cancer risk.

    PubMed  CAS  Google Scholar 

  31. Rudel LL, Haines J, Sawyer JK, et al.: Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat. J Clin Invest 1997, 100:74–83.

    Article  PubMed  CAS  Google Scholar 

  32. Higashi K, Shige H, Ito T, et al.: Effect of a low-fat diet enriched with oleic acid on postprandial lipemia in patients with type 2 diabetes mellitus. Lipids2001, 36:1–6.

    Article  PubMed  CAS  Google Scholar 

  33. Niemeijer-Kanters SD, Dallinga-Thie GM, de Ruijter-Heijstek FC, et al.: Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus. Atherosclerosis 2001, 156:209–216.

    Article  PubMed  CAS  Google Scholar 

  34. Mori TA, Burke V, Puddey IB, et al.: Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000, 71:1085–1094.

    PubMed  CAS  Google Scholar 

  35. Dreon DM, Fernstrom HA, Williams PT, Krauss RM: A very low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. Am J Clin Nutr 1999, 69:411–418. Presents data on the effects of both a moderately and extremely low fat diet on LDL particle size and density. This study found an inverse association between carbohydrate intake LDL particle and density.

    PubMed  CAS  Google Scholar 

  36. Dreon DM, Fernstrom HA, Campos H, et al.: Change in dietary saturated fat intake is correlated with change in mass of large low density lipoprotein particles in men. Am J Clin Nutr 1998, 67:828–836.

    PubMed  CAS  Google Scholar 

  37. Brown AA, Hu FB: Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001, 73:673–686.

    PubMed  CAS  Google Scholar 

  38. Okuda Y, Kawashima K, Sawada T, et al.: Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997, 232:487–491.

    Article  PubMed  CAS  Google Scholar 

  39. Johansen O, Seljeflot I, Hostmark AT, Arnesen H: The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 1999, 19:1681–1686.

    PubMed  CAS  Google Scholar 

  40. Kris-Etherton PM: AHA Science Advisory. Monounsaturated fatty acids and risk of cardiovascular disease. American Heart Association. Nutrition Committee. Circulation 1999, 100:1253–1258.

    PubMed  CAS  Google Scholar 

  41. Khosla P, Fungwe TV: Conjugated linoleic acid: effects on plasma lipids and cardiovascular function. Curr Opin Lipidol 2001, 12:31–34.

    Article  PubMed  CAS  Google Scholar 

  42. Lee KN, Kritchevsky D, Pariza MW: Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 1994, 108:19–25.

    Article  PubMed  CAS  Google Scholar 

  43. Kritchevsky D: Antimutagenic and some other effects of conjugated linoleic acid. Br J Nutr 2000, 83:459–465.

    PubMed  CAS  Google Scholar 

  44. Nicolosi RJ, Rogers EJ, Kritchevsky D, et al.: Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 1997, 22:266–277.

    PubMed  CAS  Google Scholar 

  45. Munday JS, Thompson KG, James KA: Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr 1999, 81:251–255.

    PubMed  CAS  Google Scholar 

  46. Ryder JW, Portocarrero CP, Song XM, et al.: Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 2001, 50:1149–1157.

    Article  PubMed  CAS  Google Scholar 

  47. Berdanier CD: Diabetes and nutrition: the mitochondrial part. J Nutr 2001, 131:344S-353S.

    PubMed  CAS  Google Scholar 

  48. Garg R, Elam MB, Crouse JR III, et al.: Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease. Am Heart J 2000, 140:792–803.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Segal-Isaacson, C.J., Carello, E. & Wylie-Rosett, J. Dietary fats and diabetes mellitus: Is there a good fat?. Curr Diab Rep 1, 161–169 (2001). https://doi.org/10.1007/s11892-001-0029-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-001-0029-3

Keywords

Navigation